IFI27/ISG12 Downregulates Estrogen Receptor α Transactivation by Facilitating Its Interaction With CRM1/XPO1 in Breast Cancer Cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IFI27/ISG12 Downregulates Estrogen Receptor α Transactivation by Facilitating Its Interaction With CRM1/XPO1 in Breast Cancer Cells
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-10-07
DOI
10.3389/fendo.2020.568375
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interferon α-inducible protein 27 is an oncogene and highly expressed in cholangiocarcinoma patients with poor survival
- (2019) Kun-Chun Chiang et al. Cancer Management and Research
- Pathways to Endocrine Therapy Resistance in Breast Cancer
- (2019) Md. Moquitul Haque et al. Frontiers in Endocrinology
- CRM1, a novel independent prognostic factor overexpressed in invasive breast carcinoma of poor prognosis
- (2018) Lu Yue et al. Oncology Letters
- Tamoxifen-Induced Apoptosis of MCF-7 Cells via GPR30/PI3K/MAPKs Interactions: Verification by ODE Modeling and RNA Sequencing
- (2018) Milad Rouhimoghadam et al. Frontiers in Physiology
- Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort
- (2017) Elin Richardsen et al. PLoS One
- ERα-XPO1 Cross Talk Controls Tamoxifen Sensitivity in Tumors by Altering ERK5 Cellular Localization
- (2016) Kinga Wrobel et al. MOLECULAR ENDOCRINOLOGY
- Systematic Proteomic Identification of the Heat Shock Proteins (Hsp) that Interact with Estrogen Receptor Alpha (ERα) and Biochemical Characterization of the ERα-Hsp70 Interaction
- (2016) Ahmed E. Dhamad et al. PLoS One
- IFI27, a novel epidermal growth factor-stabilized protein, is functionally involved in proliferation and cell cycling of human epidermal keratinocytes
- (2015) W.-L. Hsieh et al. CELL PROLIFERATION
- Interferon alpha-inducible protein 27 promotes epithelial–mesenchymal transition and induces ovarian tumorigenicity and stemness
- (2015) Shuqin Li et al. JOURNAL OF SURGICAL RESEARCH
- miR-942 decreases TRAIL-induced apoptosis through ISG12a downregulation and is regulated by AKT
- (2015) Nianli Liu et al. Oncotarget
- Tristetraprolin Represses Estrogen Receptor α Transactivation in Breast Cancer Cells
- (2014) Tonatiuh Barrios-García et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SIP1/NHERF2 enhances estrogen receptor alpha transactivation in breast cancer cells
- (2014) I. Meneses-Morales et al. NUCLEIC ACIDS RESEARCH
- ISG12 is a critical modulator of innate immune responses in murine models of sepsis
- (2013) P. Uhrin et al. IMMUNOBIOLOGY
- Tamoxifen Resistance in Breast Cancer
- (2012) Min-Sun Chang Biomolecules & Therapeutics
- Prosaposin, a regulator of estrogen receptor alpha, promotes breast cancer growth
- (2012) Yihong Wu et al. CANCER SCIENCE
- The Interferon Stimulated Gene 12 Inactivates Vasculoprotective Functions of NR4A Nuclear Receptors
- (2012) Nikolina Papac-Milicevic et al. CIRCULATION RESEARCH
- PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration
- (2011) Ganta Chaitanya et al. Cell Communication and Signaling
- Emerging Roles of FAM14 Family Members (G1P3/ISG 6–16 and ISG12/IFI27) in Innate Immunity and Cancer
- (2010) Venugopalan Cheriyath et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Hormone-dependent nuclear export of estradiol receptor and DNA synthesis in breast cancer cells
- (2008) Maria Lombardi et al. JOURNAL OF CELL BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started